NO20080002L - Formuleringer av konjugerte ostrogener og bazedoxifen - Google Patents
Formuleringer av konjugerte ostrogener og bazedoxifenInfo
- Publication number
- NO20080002L NO20080002L NO20080002A NO20080002A NO20080002L NO 20080002 L NO20080002 L NO 20080002L NO 20080002 A NO20080002 A NO 20080002A NO 20080002 A NO20080002 A NO 20080002A NO 20080002 L NO20080002 L NO 20080002L
- Authority
- NO
- Norway
- Prior art keywords
- bazedoxifene
- conjugated estrogens
- formulations
- salt
- estrogens
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Endocrinology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Abstract
Det beskrives faste doseringsformuleringer som inneholder konjugerte østrogener og bazedoxifen eller et salt derav. I enkelte utførelsesformer inkluderer blandingene en kjerne som omfatter konjugerte østrogener og minst ett overtrekk som omfatter bazedoxifen eller et salt derav.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US69488905P | 2005-06-29 | 2005-06-29 | |
PCT/US2006/025348 WO2007002823A2 (en) | 2005-06-29 | 2006-06-28 | Formulations of conjugated estrogens and bazedoxifene |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20080002L true NO20080002L (no) | 2008-03-12 |
Family
ID=37401610
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20080002A NO20080002L (no) | 2005-06-29 | 2008-01-02 | Formuleringer av konjugerte ostrogener og bazedoxifen |
Country Status (19)
Country | Link |
---|---|
US (1) | US20070003623A1 (no) |
EP (1) | EP1898888A2 (no) |
JP (1) | JP2008545012A (no) |
KR (1) | KR20080031037A (no) |
CN (1) | CN101252921A (no) |
AR (1) | AR054806A1 (no) |
AU (1) | AU2006263638A1 (no) |
BR (1) | BRPI0612586A2 (no) |
CA (1) | CA2613102A1 (no) |
CR (1) | CR9597A (no) |
EC (1) | ECSP078057A (no) |
IL (1) | IL188223A0 (no) |
NI (1) | NI200700331A (no) |
NO (1) | NO20080002L (no) |
PA (1) | PA8684501A1 (no) |
PE (1) | PE20070188A1 (no) |
RU (1) | RU2395286C2 (no) |
TW (1) | TW200738283A (no) |
WO (1) | WO2007002823A2 (no) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1732528A1 (en) * | 2004-04-08 | 2006-12-20 | Wyeth | Bazedoxifene acetate solid dispersion formulations |
JP2010511062A (ja) * | 2006-11-29 | 2010-04-08 | ワイス エルエルシー | エストロゲン/sermおよびエストロゲン/プロゲスチン二層錠剤 |
RU2009125413A (ru) * | 2007-01-12 | 2011-02-20 | Вайет (Us) | Композиции таблетка-в-таблетке |
PE20090100A1 (es) * | 2007-03-30 | 2009-02-26 | Wyeth Corp | Metodos de separacion y deteccion de acetato de bacedoxifeno en composiciones farmaceuticas |
ES2436841T3 (es) | 2009-10-27 | 2014-01-07 | Wyeth Llc | Formulaciones de bazedoxifeno con antioxidantes |
NZ602955A (en) * | 2010-04-20 | 2015-02-27 | Cipla Ltd | Pharmaceutical composition comprising efavirenz |
US8615061B2 (en) * | 2010-07-29 | 2013-12-24 | Entropic Communications, Inc. | Method and apparatus for cross polarization and cross satellite interference cancellation |
BR112013029199B1 (pt) * | 2011-05-13 | 2022-02-08 | Eb Ip Hybritabs B.V. | Dispositivo de distribuição de dois fármacos |
CN104013630B (zh) * | 2014-05-23 | 2018-08-21 | 合肥九研医药科技开发有限公司 | 一种复方醋酸巴多昔芬***组合物 |
KR102662025B1 (ko) | 2015-06-18 | 2024-05-02 | 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 | 에스테트롤 성분을 함유하는 구강분해성 투여 단위 |
CA3178291A1 (en) | 2016-08-05 | 2018-04-12 | Estetra Srl | Method for the management of dysmenorrhea and menstrual pain |
WO2018182205A1 (ko) * | 2017-03-30 | 2018-10-04 | 한미약품 주식회사 | 바제독시펜 아세테이트를 함유하는 안정화된 약제학적 조성물 |
JOP20200260A1 (ar) * | 2018-04-19 | 2019-10-19 | Estetra Sprl | مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث |
TWI801561B (zh) | 2018-04-19 | 2023-05-11 | 比利時商依思特拉私人有限責任公司 | 化合物及其用於緩解絕經相關症狀的用途 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2565115A (en) * | 1948-10-28 | 1951-08-21 | Squibb & Sons Inc | Method of obtaining a conjugated estrogen preparation |
US2720483A (en) * | 1951-02-21 | 1955-10-11 | Olin Mathieson | Method of obtaining a conjugatedestrogen preparation |
US5210081A (en) * | 1992-02-26 | 1993-05-11 | American Home Products Corporation | Alkali metal 8,9-dehydroestrone sulfate esters |
US5759577A (en) * | 1995-01-17 | 1998-06-02 | American Home Products Corporation | Controlled release of steroids from sugar coatings |
US5547948A (en) * | 1995-01-17 | 1996-08-20 | American Home Products Corporation | Controlled release of steroids from sugar coatings |
US5998402A (en) * | 1996-04-19 | 1999-12-07 | American Home Products Corporation | 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents |
US6479535B1 (en) * | 1998-05-15 | 2002-11-12 | Wyeth | 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations |
AU5957500A (en) * | 1999-07-06 | 2001-01-22 | Endorecherche Inc. | Methods of treating and/or suppressing weight gain |
AR029538A1 (es) * | 2000-07-06 | 2003-07-02 | Wyeth Corp | Composiciones farmaceuticas de agentes estrogenicos |
BR0311774A (pt) * | 2002-06-13 | 2007-05-08 | Wyeth Corp | regimes de tratamento com bazedoxifeno |
TW200536845A (en) * | 2004-04-07 | 2005-11-16 | Wyeth Corp | Crystalline polymorph of bazedoxifene acetate |
JP2007532560A (ja) * | 2004-04-07 | 2007-11-15 | ワイス | バゼドキシフェンアセテートの結晶多形 |
US7504394B2 (en) * | 2004-04-08 | 2009-03-17 | Wyeth | Bazedoxifene ascorbate |
EP1732528A1 (en) * | 2004-04-08 | 2006-12-20 | Wyeth | Bazedoxifene acetate solid dispersion formulations |
-
2006
- 2006-06-28 BR BRPI0612586-7A patent/BRPI0612586A2/pt not_active IP Right Cessation
- 2006-06-28 AU AU2006263638A patent/AU2006263638A1/en not_active Abandoned
- 2006-06-28 KR KR1020087002416A patent/KR20080031037A/ko not_active Application Discontinuation
- 2006-06-28 CN CNA2006800313156A patent/CN101252921A/zh active Pending
- 2006-06-28 PE PE2006000757A patent/PE20070188A1/es not_active Application Discontinuation
- 2006-06-28 WO PCT/US2006/025348 patent/WO2007002823A2/en active Application Filing
- 2006-06-28 AR ARP060102789A patent/AR054806A1/es unknown
- 2006-06-28 EP EP06785833A patent/EP1898888A2/en not_active Withdrawn
- 2006-06-28 US US11/478,400 patent/US20070003623A1/en not_active Abandoned
- 2006-06-28 RU RU2007148071/15A patent/RU2395286C2/ru not_active IP Right Cessation
- 2006-06-28 CA CA002613102A patent/CA2613102A1/en not_active Abandoned
- 2006-06-28 TW TW095123252A patent/TW200738283A/zh unknown
- 2006-06-28 JP JP2008520286A patent/JP2008545012A/ja not_active Withdrawn
- 2006-06-29 PA PA20068684501A patent/PA8684501A1/es unknown
-
2007
- 2007-12-17 CR CR9597A patent/CR9597A/es not_active Application Discontinuation
- 2007-12-18 NI NI200700331A patent/NI200700331A/es unknown
- 2007-12-18 IL IL188223A patent/IL188223A0/en unknown
- 2007-12-27 EC EC2007008057A patent/ECSP078057A/es unknown
-
2008
- 2008-01-02 NO NO20080002A patent/NO20080002L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP2008545012A (ja) | 2008-12-11 |
TW200738283A (en) | 2007-10-16 |
NI200700331A (es) | 2009-02-16 |
WO2007002823A2 (en) | 2007-01-04 |
AR054806A1 (es) | 2007-07-18 |
PE20070188A1 (es) | 2007-03-16 |
IL188223A0 (en) | 2008-03-20 |
BRPI0612586A2 (pt) | 2010-11-23 |
RU2395286C2 (ru) | 2010-07-27 |
US20070003623A1 (en) | 2007-01-04 |
PA8684501A1 (es) | 2007-01-17 |
KR20080031037A (ko) | 2008-04-07 |
WO2007002823A3 (en) | 2007-08-09 |
ECSP078057A (es) | 2008-01-23 |
AU2006263638A1 (en) | 2007-01-04 |
RU2007148071A (ru) | 2009-08-10 |
EP1898888A2 (en) | 2008-03-19 |
CN101252921A (zh) | 2008-08-27 |
CA2613102A1 (en) | 2007-01-04 |
CR9597A (es) | 2008-03-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20080002L (no) | Formuleringer av konjugerte ostrogener og bazedoxifen | |
RS50660B (sr) | Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže | |
RS50510B (sr) | Formulacije koje sadrže ekteinascidin i disaharid | |
BRPI0814593A2 (pt) | Composto, composição farmacêutica que o contém e uso do composto. | |
UY31145A1 (es) | Derivado de 17b+ciano-18a-homo-19-nor-androst-4-eno, su uso y medicamento que lo contiene | |
RS52169B (en) | STABLE LAKVINIMOD PREPARATIONS | |
NO20082376L (no) | Farmasoytiske sammensetninger | |
IL178128A0 (en) | Salts of 3-0-(3',3'-dimethyl-succinyl) betulinic acid and pharmaceutical compositions containing the same | |
CY1109010T1 (el) | γ-ΚΡΥΣΤΑΛΛΙΚΗ ΜΟΡΦΗ ΤΗΣ ΥΔΡΟΧΛΩΡΙΚΗΣ ΙΒΑΒΡΑΔΙΝΗΣ, ΜΕΘΟΔΟΣ ΠΑΡΑΣΚΕΥΗΣ ΤΗΣ ΚΑΙ ΦΑΡΜΑΚΕΥΤΙΚΕΣ ΣΥΝΘΕΣΕΙΣ ΠΟΥ ΤΗΝ ΠΕΡΙΕΧΟΥΝ | |
BRPI0715579A2 (pt) | "composto, composição farmacêutica e uso de um composto" | |
CY1109916T1 (el) | Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις | |
BRPI0407373A (pt) | Espuma hidro-alcoólica formando espuma em filme | |
NO20071944L (no) | Hydrolysestabil beleggingsmiddelsammensetning | |
GT200800107A (es) | Formulaciones orales que comprenden tigeciclina | |
EA200900267A1 (ru) | КОМПОЗИЦИЯ ДЛЯ АЭРОЗОЛЬНОЙ ИНГАЛЯЦИИ β-АГОНИСТОВ И СТЕРОИДОВ | |
BRPI0717369A2 (pt) | Composto, medicamento, composição farmacêutica que o contém e uso do composto. | |
HK1104823A1 (en) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof i | |
NO20045385L (no) | Farmasoytisk preparat inneholdende okskarbazepin med kontrollert frigivelse av aktivt stoff | |
NO20061316L (no) | Imidazopyndinderivater som induserbare NO-syntaseinhibitorer | |
IL181216A0 (en) | 3, 5-seco-4-norcholestane derivatives and pharmaceutical compositions containing the same | |
EP1797077A4 (en) | BENZIMIDAZOLE DERIVATIVES, COMPOSITIONS CONTAINING THEM, PREPARATION THEREOF AND APPLICATIONS THEREOF | |
MEP34308A (en) | Oral formulations of cladribine | |
RS51534B (en) | NEW COMPOUND OF SINUSOID IF CURRENT INHIBITORS AND CALCIUM INHIBITOR AND PHARMACEUTICAL MIXTURE CONTAINED BY IT | |
EA200801139A1 (ru) | Композиция для аэрозольной ингаляции | |
EA200300128A1 (ru) | Фармацевтические композиции, содержащие карбонат лития |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |